FDA Inspection 1017391 — Dr. Rubin H. Saavedra
The FDA completed an inspection of Dr. Rubin H. Saavedra on June 16, 2017 in Las Vegas, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 16, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Las Vegas, NV (United States)
Additional Details
Clinical Investigator (CI)